Continuum Advisory »

BioMarin Pharmaceutical shares owned by Continuum Advisory

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 101k 59.43
2025-03-31 $778 11 70.73
2024-12-31 $1.1k 17 65.71
2024-09-30 $1.8k 27 65.59
2024-06-30 $2.9k 35 82.34
2024-03-31 $2.9k 35 81.71

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Pimco Multisector Bond Active Exchange-traded Fund Etf (PYLD)
Capital Group Core Bond Etf Etf (CGCB)
Vanguard Total Stock Market Etf Etf (VTI)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Nvidia Corporation Stock (NVDA)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
Ishares S&p 100 Etf Etf (OEF)
State Street Spdr Msci Usa Strategicfactors Etf Etf (QUS)

View all positions for Continuum Advisory

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Norges Bank Investment Management
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Millennium Management
Capital Research Global Investors
UBS Group
Deep Track Capital

View all funds holding BioMarin Pharmaceutical